Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Markers of systemic involvement in chronic obstructive pulmonary disease.

Albu A, Fodor D, Poantă L, Man M.

Rom J Intern Med. 2012 Apr-Jun;50(2):129-34. Review.

PMID:
23326956
2.

Systemic effects of chronic obstructive pulmonary disease.

Agustí AG.

Proc Am Thorac Soc. 2005;2(4):367-70; discussion 371-2. Review.

PMID:
16267364
3.

Exercise-induced systemic effects in muscle-wasted patients with COPD.

Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN.

Med Sci Sports Exerc. 2006 Sep;38(9):1543-52.

PMID:
16960513
4.

Airway bacterial colonization: the missing link between COPD and cardiovascular events?

Fuschillo S, Martucci M, Donner CF, Balzano G.

Respir Med. 2012 Jul;106(7):915-23. doi: 10.1016/j.rmed.2012.03.023. Epub 2012 Apr 29. Review.

5.
6.

Systemic inflammation and mortality in chronic obstructive pulmonary disease.

Sin DD, Man SF.

Can J Physiol Pharmacol. 2007 Jan;85(1):141-7. Review.

PMID:
17487253
7.

Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.

Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A.

Respir Med. 2007 Aug;101(8):1670-6. Epub 2007 Apr 20.

8.

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.

Karadag F, Kirdar S, Karul AB, Ceylan E.

Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.

PMID:
18249305
9.

The role of oxidative stress in COPD: current concepts and perspectives.

Cavalcante AG, de Bruin PF.

J Bras Pneumol. 2009 Dec;35(12):1227-37. Review. English, Portuguese.

10.

Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective.

Andreassen H, Vestbo J.

Eur Respir J Suppl. 2003 Nov;46:2s-4s. Review.

11.

Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.

Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A.

Free Radic Biol Med. 2003 Jul 15;35(2):140-8.

PMID:
12853070
12.

Oxidant metabolism in chronic obstructive pulmonary disease.

Boots AW, Haenen GR, Bast A.

Eur Respir J Suppl. 2003 Nov;46:14s-27s. Review.

13.

Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease.

Kersul AL, Iglesias A, Ríos Á, Noguera A, Forteza A, Serra E, Agustí A, Cosío BG.

Arch Bronconeumol. 2011 Apr;47(4):176-83. doi: 10.1016/j.arbres.2010.12.003. Epub 2011 Mar 31.

14.

Chronic obstructive pulmonary disease: effects beyond the lungs.

Balasubramanian VP, Varkey B.

Curr Opin Pulm Med. 2006 Mar;12(2):106-12. Review.

PMID:
16456379
16.

Systemic manifestations in chronic obstructive pulmonary disease.

Dourado VZ, Tanni SE, Vale SA, Faganello MM, Sanchez FF, Godoy I.

J Bras Pneumol. 2006 Mar-Apr;32(2):161-71. Review. English, Portuguese.

18.

[Comorbidities of COPD].

Watz H, Magnussen H.

Internist (Berl). 2006 Sep;47(9):895-6, 898-900. Review. German.

PMID:
16821069
19.

[COPD, a systemic disease!… or not?].

Burgel PR, Marchand E.

Rev Mal Respir. 2010 Dec;27(10):1128-9. doi: 10.1016/j.rmr.2010.10.022. Epub 2010 Nov 18. French. No abstract available.

PMID:
21163390
20.

Local inflammation occurs before systemic inflammation in patients with COPD.

He Z, Chen Y, Chen P, Wu G, Cai S.

Respirology. 2010 Apr;15(3):478-84. doi: 10.1111/j.1440-1843.2010.01709.x. Epub 2010 Feb 24.

PMID:
20210891

Supplemental Content

Support Center